Traws Pharma, Inc. (TRAW) › RevenueTraws Pharma, Inc. (TRAW) — RevenueAnnual figures by fiscal year, from SEC filings.2011: $1.49M2012: $46.19M2013: $4.75M2014: $800.0K2015: $11.46M2016: $5.55M2017: $787.0K2018: $1.23M2019: $2.18M2020: $231.0K2021: $226.0K2022: $226.0K2023: $226.0K2024: $226.0K2025: $2.79M$2.79M2011Revenue (USD)2025Fiscal YearRevenueChange YoY2025$2.79M+1134.5%2024$226.0K+0.0%2023$226.0K+0.0%2022$226.0K+0.0%2021$226.0K-2.2%2020$231.0K-89.4%2019$2.18M+77.8%2018$1.23M+56.0%2017$787.0K-85.8%2016$5.55M-51.6%2015$11.46M+1332.0%2014$800.0K-83.2%2013$4.75M-89.7%2012$46.19M+3006.3%2011$1.49M—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share